Your browser doesn't support javascript.
loading
Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study.
Felker, G Michael; McMurray, John J V; Cleland, John G; O'Connor, Christopher M; Teerlink, John R; Voors, Adriaan A; Belohlavek, Jan; Böhm, Michael; Borentain, Maria; Bueno, Hector; Cole, Robert T; DeSouza, Mary M; Ezekowitz, Justin A; Filippatos, Gerasimos; Lang, Ninian N; Kessler, Paul D; Martinez, Felipe A; Mebazaa, Alex; Metra, Marco; Mosterd, Arend; Pang, Peter S; Ponikowski, Piotr; Sato, Naoki; Seiffert, Dietmar; Ye, June.
Afiliação
  • Felker GM; Duke University School of Medicine and the Duke Clinical Research Institute, Durham, North Carolina, USA. Electronic address: michael.felker@duke.edu.
  • McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
  • Cleland JG; Robertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, Glasgow Royal Infirmary, Glasgow, United Kingdom and National Heart & Lung Institute Imperial College, London, United Kingdom.
  • O'Connor CM; Inova Heart and Vascular Institute, Falls Church, Virginia, USA.
  • Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Voors AA; University of Groningen, Department of Cardiology, University Medical Center Groningen, Groningen, the Netherlands.
  • Belohlavek J; 2nd Department of Internal Medicine, Cardiovascular Medicine, General University Hospital, Charles University in Prague, Czech Republic.
  • Böhm M; Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Saarland University, Homburg/Saar, Germany.
  • Borentain M; Bristol-Myers-Squibb, Princeton, New Jersey, USA.
  • Bueno H; Cardiology Department, Hospital Universitario 12 de Octubre and Instituto de Investigación Sanitaria Hospital 12 de Octubre, Madrid, Spain.
  • Cole RT; Inova Heart and Vascular Institute, Falls Church, Virginia, USA.
  • DeSouza MM; Bristol-Myers-Squibb, Princeton, New Jersey, USA.
  • Ezekowitz JA; Canadian VIGOUR Centre at the University of Alberta, Edmonton, Alberta, Canada.
  • Filippatos G; National and Kapodisrian University of Athens, School of Medicine, Athens, Greece.
  • Lang NN; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
  • Kessler PD; Bristol-Myers-Squibb, Princeton, New Jersey, USA.
  • Martinez FA; Instituto DAMIC, Cordoba National University Cordoba, Argentina.
  • Mebazaa A; Department of Anaesthesiology and Critical Care Medicine, Saint Louis Lariboisière University Hospitals, Assistance Publique - Hôpitaux de Paris, Université de Paris, Inserm 942-MASCOT, FHU PROMICE, Paris, France.
  • Metra M; Institute of Cardiology, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
  • Mosterd A; Department of Cardiology, Meander Medical Center, Amersfoort, the Netherlands and Dutch Network for Cardiovascular Research, Utrecht, the Netherlands.
  • Pang PS; Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Ponikowski P; Wroclaw Medical University, Wroclaw, Poland.
  • Sato N; Cardiology and Intensive Care Unit, Nippon Medical School, Musashi-Kosugi Hospital, Kawasaki, Japan.
  • Seiffert D; Bristol-Myers-Squibb, Princeton, New Jersey, USA.
  • Ye J; Bristol-Myers-Squibb, Princeton, New Jersey, USA.
JACC Heart Fail ; 9(2): 146-157, 2021 02.
Article em En | MEDLINE | ID: mdl-33248986

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Cardíaca Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Cardíaca Idioma: En Ano de publicação: 2021 Tipo de documento: Article